Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity.
Gorline L, do Carmo FLR, Bourdely P, Bornères J, Vaudiau N, Semervil A, Vetillard M, Coulibaly ASK, Jugniot N, Ok A, Bausart M, Fiquet O, Andrade M, Fardol D, Haddar I, Abou Nader Z, Weber J, Theobald H, Collin M, Calmette J, Anselmi G, Fico F, Ginhoux F, Majlessi L, Gautier EL, Saveanu L, Helft J, Dalod M, Dusseaux M, Di Santo JP, Hugues S, Guermonprez P.
Gorline L, et al. Among authors: collin m.
Nat Commun. 2025 Dec 30. doi: 10.1038/s41467-025-68018-3. Online ahead of print.
Nat Commun. 2025.
PMID: 41469380
Free article.